Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | CTSL | P07711 | 4/20 | 0.51 |
| ▸ | CTSS | P25774 | 2/20 | 0.51 |
| ▸ | CTSK | P43235 | 2/20 | 0.51 |
| ▸ | CTSB | P07858 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | GFER | P55789 | 1/20 | 0.51 |
| ▸ | GPR139 | Q6DWJ6 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28231704 | 0.87 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1RAB9AHPGDCTSL | |
| SCHEMBL28231702 | 0.87 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1RAB9AHPGDCTSL | |
| SCHEMBL11517236 | 0.85 | SMN1; SMN2 (0.52) | GAASMN1; SMN2ALDH1A1RAB9AHPGD | |
| SCHEMBL4075735 | 0.83 | ALDH1A1 (0.61) | GAASMN1; SMN2ALDH1A1RAB9AHPGD | |
| SCHEMBL7413732 | 0.82 | SMN1; SMN2 (0.59) | SMN1; SMN2ALDH1A1RAB9AHPGDLMNA | |
| SCHEMBL28743340 | 0.82 | SMN1; SMN2 (0.59) | SMN1; SMN2ALDH1A1RAB9AHPGDLMNA | |
| SCHEMBL3658406 | 0.82 | SMN1; SMN2 (0.59) | SMN1; SMN2ALDH1A1RAB9AHPGDCTSL | |
| SCHEMBL11431508 | 0.81 | SMN1; SMN2 (0.57) | SMN1; SMN2LMNAGFERGPR139 | |
| SCHEMBL10040931 | 0.80 | CTSL (0.60) | GAASMN1; SMN2ALDH1A1RAB9AHPGD | |
| SCHEMBL2796740 | 0.80 | CA1 (0.62) | SMN1; SMN2ALDH1A1RAB9AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8207107-B2 | Di-amido gellant for use in consumer product compositions | THE PROCTER & GAMBLE COMPANY (US) | 2012-06-26 | — | — | US | disclosed |
| US-8168579-B2 | Fluid detergent compositions comprising a di-amido gellant, and processes for making | THE PROCTER AND GAMBLE COMPANY (US) | 2012-05-01 | — | — | US | disclosed |
| US-20110220536-A1 | Fluid Detergent Compositions Comprising a Di-Amido Gellant, and Processes for Making | THE PROCTER & GAMBLE COMPANY | 2011-09-15 | — | — | US | disclosed |
| US-20110224455-A1 | Di-Amido Gellant For Use In Consumer Product Compositions | THE PROCTER & GAMBLE COMPANY | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224455-A1 | Di-Amido Gellant For Use In Consumer Product Compositions | DAGLA, GNPAT, CDIPT | GAA 661/4885SMN1; SMN2 3740/4885ALDH1A1 1506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.